New dissolving stent could offer hope for chronic watery eyes
NCT ID NCT07499791
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new absorbable stent that releases medication to keep the tear duct open after surgery for recurrent chronic dacryocystitis (blocked tear ducts). Forty adults who have had a previous failed surgery will be randomly assigned to receive either the new stent or standard packing with a nasal spray. The goal is to see if the stent improves symptoms and keeps the duct open better than current methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Absorbable lacrimal sac drug-eluting stent (coated with mometasone furoate)
What this could lead to
If successful, this stent could offer a better way to treat recurrent blocked tear ducts, reducing the need for repeat surgeries.
What could go wrong
This is a small, early-phase trial with only 40 participants. The stent may not work better than standard care, and risks include allergy to the drug or material, or the stent not dissolving properly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC DACRYOCYSTITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing 100000
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••